Healthcare Value Capital Upped By $3.00 Million Its Depomed (DEPO) Stake; Oppenheimer Holdings Has 1.16 Sentiment

January 16, 2018 - By Linda Rogers

Healthcare Value Capital Llc increased Depomed Inc (DEPO) stake by 600% reported in 2017Q3 SEC filing. Healthcare Value Capital Llc acquired 600,000 shares as Depomed Inc (DEPO)’s stock declined 38.37%. The Healthcare Value Capital Llc holds 700,000 shares with $4.05 million value, up from 100,000 last quarter. Depomed Inc now has $512.30 million valuation. The stock decreased 2.40% or $0.2 during the last trading session, reaching $8.13. About 835,737 shares traded. Depomed, Inc. (NASDAQ:DEPO) has declined 46.86% since January 16, 2017 and is downtrending. It has underperformed by 63.56% the S&P500.

Oppenheimer Holdings Inc. provides middle-market investment banking and full service broker-dealer services and products. The company has market cap of $350.02 million. The firm offers full-service brokerage services covering exchange-traded and over-the-counter corporate equity and debt securities, money market instruments, exchange-traded options and futures contracts, municipal bonds, mutual funds, and unit investment trusts; financial and wealth planning services; and margin lending services. It currently has negative earnings. It also provides asset management services, including separately managed accounts, mutual fund managed accounts, discretionary portfolio management programs, fee non-discretionary investment advisory services, alternative investments, portfolio enhancement programs, investment advisory services, and institutional taxable fixed income portfolio management services.

Investors sentiment increased to 1.21 in 2017 Q3. Its up 0.34, from 0.87 in 2017Q2. It is positive, as 23 investors sold DEPO shares while 40 reduced holdings. 24 funds opened positions while 52 raised stakes. 56.42 million shares or 3.13% more from 54.71 million shares in 2017Q2 were reported. Ballentine Partners Ltd Company invested 0.01% in Depomed, Inc. (NASDAQ:DEPO). Susquehanna Intl Limited Liability Partnership has invested 0% of its portfolio in Depomed, Inc. (NASDAQ:DEPO). Credit Suisse Ag, a Switzerland-based fund reported 65,021 shares. Zurcher Kantonalbank (Zurich Cantonalbank) reported 0% of its portfolio in Depomed, Inc. (NASDAQ:DEPO). The Alberta – Canada-based Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Mgmt has invested 0.01% in Depomed, Inc. (NASDAQ:DEPO). Alliancebernstein LP holds 0% of its portfolio in Depomed, Inc. (NASDAQ:DEPO) for 71,446 shares. Aqr Capital Management Lc invested in 76,518 shares or 0% of the stock. Connor Clark Lunn Invest Mgmt reported 332,034 shares stake. Franklin Street Advsrs Inc Nc owns 0.02% invested in Depomed, Inc. (NASDAQ:DEPO) for 20,000 shares. Ahl Ptnrs Limited Liability Partnership has invested 0% in Depomed, Inc. (NASDAQ:DEPO). Invesco has invested 0% in Depomed, Inc. (NASDAQ:DEPO). Principal Group has invested 0% of its portfolio in Depomed, Inc. (NASDAQ:DEPO). Deutsche National Bank Ag reported 172,136 shares. Thrivent For Lutherans holds 38,590 shares or 0% of its portfolio. State Board Of Administration Of Florida Retirement Sys reported 46,655 shares or 0% of all its holdings.

Among 14 analysts covering Depomed Inc (NASDAQ:DEPO), 6 have Buy rating, 2 Sell and 6 Hold. Therefore 43% are positive. Depomed Inc had 50 analyst reports since July 30, 2015 according to SRatingsIntel. The company was initiated on Tuesday, February 9 by UBS. The firm has “Neutral” rating by Mizuho given on Thursday, January 7. The stock of Depomed, Inc. (NASDAQ:DEPO) has “Neutral” rating given on Monday, October 3 by UBS. Piper Jaffray maintained the shares of DEPO in report on Friday, July 14 with “Hold” rating. RBC Capital Markets maintained it with “Hold” rating and $6.0 target in Wednesday, November 8 report. The firm has “Buy” rating given on Tuesday, December 5 by Mizuho. The firm earned “Outperform” rating on Thursday, March 10 by Leerink Swann. The stock has “Buy” rating by WallachBeth Capital on Wednesday, February 24. The rating was upgraded by WallachBeth Capital to “Buy” on Wednesday, November 11. The rating was maintained by RBC Capital Markets with “Hold” on Thursday, September 14.

Since December 14, 2017, it had 1 buying transaction, and 0 selling transactions for $612,000 activity. HIGGINS ARTHUR J bought $612,000 worth of Depomed, Inc. (NASDAQ:DEPO) on Thursday, December 14.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: